The certification will be applied for with the Medical Association of Saxony.
08:30–10:00 am New insights into lipid metabolism
Plenary Session 1 – New insights into lipid metabolism Chairs: U. Laufs | R. Burkhardt
Are Lp(a) particles pathogenic beyond their cholesterol content? F. Kronenberg
Effecs of obesity on lipoproteins J. Heeren
10:00–10:15 am | Coffee Break
10:15–11:20 am Neuronal control of metabo‐vascular disease
Neuronal control of metabo‐vascular disease Chairs: S. Zimmermann | M. Gericke
The nervous system, obesity and lipid metabolism J. Brüning
Regional diversity of brain lipid composition in the context of cerebral ischemia D. Fitzner
10:15–11:20 am Effects of anticoagulants beyond hemostasis
Effects of anticoagulants beyond hemostasis Chairs: C. Pfrepper | B. Isermann
DOACs and vascular disease K. Shahzad
Pleiotropic Effects of the Protease‐Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation U. Rauch-Kröhnert
11:20–11:40 am | Short Break
11:40–12:45 pm Early mechanisms of obesity
Early mechanisms of obesity Chairs: S. Kohli | A. Zenclussen
Mat. obesity primes macrophages towards liver disease in offsprings E. Mass
In utero priming of diabetes S. Ozanne
11:40–12:45 pm Innovative clinical aspects in CVD
Innovative clinical aspects in CVD Chairs: U. Laufs | J. Bauersachs
Interventional angiology S. Steiner
Genome-wide meta-analysis of phytosterols reveals novel loci and a detrimental effect on coronary atherosclerosis M. Scholz
12:45–02:30 pm | Lunch Break
02:30–04:00 pm Endothelial cells and inflammation as CVD drivers
Plenary Session 2 – Endothelial cells and inflammation as CVD drivers Chairs: A. Fischer | T. Chavakis
Bone marrow endothelial cells in health, age and disease A. Kusumbe
Lipids and vascular inflammation P. Libby
04:00–04:30 pm | Coffee Break
04:30–05:10 pm Role and function of the mircovasculature
Role and function of the mircovasculature Chairs: K. Shahzad | S. Steiner
Heterogeneity and functional specialization of blood vessels in bone R. Adams
04:30–05:10 pm Innovative therapeutic approaches in CVD
Innovative therapeutic approaches in CVD Chairs: H. Thiele | R. Wachter
Molecular effects of Bempedoic acid B. Sheikh
05:10–06:25 pm Chairs: R. Biemann, M. Heinemann, K. Shahzad, S. Zimmermann